Novel exendin agonist formulations and methods administration thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- AMYLIN PHARMACEUTICALS LLC
- Publication Date
- 2002-12-11
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] related application
[0002] This application claims priority to U.S. Provisional Application 60 / 116,380, filed January 14, 1999, entitled "Novel Exendin Agonist Formulations and Methods of Administering Same" and filed January 14, 1999, entitled " Use of exendin and agonists thereof for the regulation of triglyceride levels and the treatment of lipid disorders" US Provisional Application 60 / [not yet assigned], the contents of which are incorporated herein by reference. field of invention
[0003] The present invention relates to novel exendin and peptide exendin agonist formulations, dosages, and formulations that are biologically active and can be delivered by injectable and non-injective routes such as the respiratory, oral, and gastrointestinal tracts. These formulations and dosages and methods of administration are useful in the treatment of diabetes, including type I and type II diabetes mellitus, in th...